{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:00:39Z","timestamp":1789610439843,"version":"build-2803163510"},"reference-count":24,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":2124,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,5]]},"abstract":"<jats:p>We conducted a systematic review and meta-analysis of published randomised controlled trials of dapoxetine for premature ejaculation. We systematically searched Embase, PubMed, Cochrane, Web of Knowledge, FDA.gov and Clinical Trials.gov for studies reporting dapoxetine in men with premature ejaculation. Efficacy endpoints included intravaginal ejaculatory latency times (IELT), personal distress related to ejaculation (PDRE) and treatment-emergent adverse events (TEAEs) was used to evaluate safety. Data were analysed using a random-effects model. Electronic search identified 276 papers. The final analysis included eight papers (n = 8422 subjects). Analysis of the pooled results indicated efficacy in both IELT (weighted mean difference (WMD) = 1.67, 95% confidence interval (CI) 1.45\u20131.89) and PDRE (relative risk = 1.26, 95% CI 1.18\u20131.35). Subgroup analysis indicated efficacy (i.e. increase in IELT) for 30- and 60-mg on-demand dapoxetine (WMD 1.38 (95% CI 1.01\u20131.75) and 1.62 (95% CI 1.40\u20131.84) respectively), as well as daily use of 60 mg dapoxetine (WMD 2.18, 95% CI 1.71\u20132.64). The safety profile was acceptable. Based on the different effects of magnitude of the three dosing regimens, we recommend a stepwise approach, starting with 30 mg on demand, then 60 mg on demand and finally 60 mg dapoxetine daily.<\/jats:p>","DOI":"10.1071\/sh18005","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T23:21:11Z","timestamp":1562887271000},"page":"301-313","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of dapoxetine for premature ejaculation: an updated systematic review and meta-analysis\u2020"],"prefix":"10.1071","volume":"16","author":[{"given":"Guo-Jiang","family":"Zhao","sequence":"first","affiliation":[{"name":"ADepartment of Urology, Shanxi Dayi Hospital Affiliated to Shanxi Medical University, 99 Longcheng Street, Taiyuan, Shanxi 030024, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[{"name":"BDepartment of Urology, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, Shanxi 030001, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Li","sequence":"additional","affiliation":[{"name":"CDepartment of Neurology, Shanxi Dayi Hospital Affiliated to Shanxi Medical University, 99 Longcheng Street, Taiyuan, Shanxi 030024, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Gang","family":"Zhang","sequence":"additional","affiliation":[{"name":"ADepartment of Urology, Shanxi Dayi Hospital Affiliated to Shanxi Medical University, 99 Longcheng Street, Taiyuan, Shanxi 030024, China."},{"name":"DCorresponding author Email: urozyg@163.com"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"issue":"1","key":"2025102419081706300_R1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF01542979","article-title":"An analysis of self-reported sexual behavior in a sample of normal males.","volume":"13","author":"Reading","year":"1984","journal-title":"Arch Sex Behav"},{"issue":"4","key":"2025102419081706300_R2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/00926238608415413","article-title":"The epidemiology of the DSM-III psychosexual dysfunctions.","volume":"12","author":"Nathan","year":"1986","journal-title":"J Sex Marital Ther"},{"issue":"4","key":"2025102419081706300_R3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.2044-8341.1986.tb02704.x","article-title":"The prevalence and perceived aetiology of male sexual problems in a non-clinical sample.","volume":"59","author":"Spector","year":"1986","journal-title":"Br J Med Psychol"},{"issue":"4","key":"2025102419081706300_R4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF01541933","article-title":"Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature.","volume":"19","author":"Spector","year":"1990","journal-title":"Arch Sex Behav"},{"issue":"6","key":"2025102419081706300_R5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: prevalence and predictors.","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"2025102419081706300_R6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.eururo.2006.07.004","article-title":"The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking.","volume":"51","author":"Porst","year":"2007","journal-title":"Eur Urol"},{"issue":"1","key":"2025102419081706300_R7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1023\/A:1024569319319","article-title":"The relationships among ejaculatory control, ejaculatory latency, and attempts to prolong heterosexual intercourse.","volume":"26","author":"Grenier","year":"1997","journal-title":"Arch Sex Behav"},{"issue":"5","key":"2025102419081706300_R8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.eururo.2015.12.028","article-title":"Current pharmacological management of premature ejaculation: a systematic review and meta-analysis.","volume":"69","author":"Castiglione","year":"2016","journal-title":"Eur Urol"},{"key":"2025102419081706300_R9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomised clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"5","key":"2025102419081706300_R10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"issue":"11","key":"2025102419081706300_R11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"1","key":"2025102419081706300_R12","doi-asserted-by":"publisher","DOI":"10.1111\/and.12829","article-title":"Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial.","volume":"50","author":"Abu El-Hamd","year":"2018","journal-title":"Andrologia"},{"issue":"5","key":"2025102419081706300_R13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1464-410X.2008.08165.x","article-title":"Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.","volume":"103","author":"Kaufman","year":"2009","journal-title":"BJU Int"},{"issue":"7","key":"2025102419081706300_R14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/j.1464-410X.2008.07845.x","article-title":"Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from Phase III trials with dapoxetine.","volume":"102","author":"Shabsigh","year":"2008","journal-title":"BJU Int"},{"issue":"5","key":"2025102419081706300_R15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.WNF.0000228210.12194.46","article-title":"Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.","volume":"29","author":"Safarinejad","year":"2006","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"2025102419081706300_R16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled Phase 3 trial in 22 countries.","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"issue":"1 Pt 1","key":"2025102419081706300_R17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1743-6109.2009.01560.x","article-title":"Treatment of premature ejaculation in the Asia\u2013Pacific region: results from a Phase III double-blind, parallel-group study of dapoxetine.","volume":"7","author":"McMahon","year":"2010","journal-title":"J Sex Med"},{"issue":"9539","key":"2025102419081706300_R18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"2025102419081706300_R19","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/sj.npp.1301500","article-title":"Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.","volume":"33","author":"Safarinejad","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2025102419081706300_R20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0091270005284850","article-title":"Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation.","volume":"46","author":"Modi","year":"2006","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"2025102419081706300_R21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/ijir.2015.16","article-title":"Paternal dapoxetine administration induced deterioration in reproductive performance, fetal outcome, sexual behavior and biochemistry of male rats.","volume":"27","author":"ElMazoudy","year":"2015","journal-title":"Int J Impot Res"},{"key":"2025102419081706300_R22","first-page":"007","article-title":"Effect of dapoxetine on sperm quality and DNA fragmentation index in vitro.","volume":"7","author":"Yu","year":"2017","journal-title":"J Mod Urol"},{"key":"2025102419081706300_R23"},{"issue":"1","key":"2025102419081706300_R24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/sj.ijir.3901420","article-title":"Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors.","volume":"18","author":"Dresser","year":"2006","journal-title":"Int J Impot Res"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/16\/4\/301\/149420\/sh18005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/16\/4\/301\/149420\/sh18005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T23:08:25Z","timestamp":1761347305000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/16\/4\/301\/21525\/Efficacy-and-safety-of-dapoxetine-for-premature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8,5]]}},"URL":"https:\/\/doi.org\/10.1071\/sh18005","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]}}}